Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response

M. Shichiri; R. Kawamori; N. Hakui; Yoshimitsu Yamasaki; H. Abe

doi:10.2337/diabetes.33.12.1200

ScienceGate Book Chapters

JOURNAL ARTICLE

Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response

M. Shichiri R. Kawamori N. Hakui Yoshimitsu Yamasaki H. Abe

Year: 1984 Journal: Diabetes Vol: 33 (12)Pages: 1200-1202 Publisher: American Diabetes Association

DOI: 10.2337/diabetes.33.12.1200

Get Full-Text PDF Get Analytical Report

Keywords:

Glycemic Artificial pancreas Medicine Insulin Endocrine system Closed loop Internal medicine Endocrinology Diabetes mellitus Type 1 diabetes Hormone Control engineering Engineering

Metrics

Cited By

1.61

FWCI (Field Weighted Citation Impact)

Refs

0.82

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Diabetes Management and Research

Health Sciences → Medicine → Endocrinology, Diabetes and Metabolism

Diabetes and associated disorders

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

Hyperglycemia and glycemic control in critically ill and hospitalized patients

Health Sciences → Medicine → Endocrinology, Diabetes and Metabolism

Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response

Metrics

Citation History

Topics

Related Documents

Closed-Loop Glycemic Control with a Wearable Artificial Endocrine Pancreas Variations in Daily Insulin Requirements to Glycemic Response

Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas

Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia

Diabetes, December 1984, pp 1200-1202. Closed-loop glycemic control with a wearable artificial endocrine pan creas

Closed-Loop Insulin for Glycemic Control in Noncritical Care.